BIOMAT Database Logo BIOMAT Database Logo

Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone. 1983

M Arisawa, and J Ohshima, and H B Maruyama

Several Citrobacter freundii beta-lactamases, discernible by their substrate profiles and sensitivities to inhibition by newer cephalosporins, were inhibited by ceftriaxone in an unusual manner. Inhibition was noncompetitive at low concentrations of cephaloridine but became competitive at concentrations above 600 muM, which is close to the K(m) (570 muM) for cephaloridine.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002509 Cephaloridine A cephalosporin antibiotic. Cefaloridine,Cephalomycine,Cephaloridin,Ceporin
D002954 Citrobacter A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D065093 beta-Lactamase Inhibitors Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. beta Lactamase Inhibitor,beta Lactamase Inhibitors,beta-Lactamase Inhibitor,beta Lactamase Antagonists,Antagonists, beta Lactamase,Inhibitor, beta Lactamase,Inhibitor, beta-Lactamase,Inhibitors, beta Lactamase,Inhibitors, beta-Lactamase,Lactamase Antagonists, beta,Lactamase Inhibitor, beta,Lactamase Inhibitors, beta

Related Publications

M Arisawa, and J Ohshima, and H B Maruyama
Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.
May 2002, Antimicrobial agents and chemotherapy,
M Arisawa, and J Ohshima, and H B Maruyama
Successful treatment of neonatal Citrobacter freundii meningitis with ceftriaxone.
January 1991, DICP : the annals of pharmacotherapy,
M Arisawa, and J Ohshima, and H B Maruyama
Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.
January 1988, Antimicrobial agents and chemotherapy,
M Arisawa, and J Ohshima, and H B Maruyama
Canaliculitis caused by Citrobacter freundii.
December 2016, Clinical & experimental ophthalmology,
M Arisawa, and J Ohshima, and H B Maruyama
Broad spectrum beta-lactamases of Citrobacter diversus.
March 1990, The Journal of antimicrobial chemotherapy,
M Arisawa, and J Ohshima, and H B Maruyama
[Citrobacter freundii endocarditis].
July 1999, Anales de medicina interna (Madrid, Spain : 1984),
M Arisawa, and J Ohshima, and H B Maruyama
Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii.
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
M Arisawa, and J Ohshima, and H B Maruyama
Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains.
January 1999, Microbial drug resistance (Larchmont, N.Y.),
M Arisawa, and J Ohshima, and H B Maruyama
Ecthyma gangrenosum caused by Citrobacter freundii.
July 2017, BMJ case reports,
M Arisawa, and J Ohshima, and H B Maruyama
Beta-lactamase production in Enterobacter cloacae and Citrobacter freundii.
December 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
Copied contents to your clipboard!